Bożena Kuran
First Faculty of Medicine, Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bożena Kuran.
Journal of Liquid Chromatography & Related Technologies | 2006
Urszula Kijkowska-Murak; Dariusz Matosiuk; Anna Hawrył; Monika Waksmundzka-Hajnos; Bożena Kuran; Jerzy Kossakowski
Abstract The lipophilicities of twelve 3,5‐dioxo‐4‐azatricyclo[5.2.2.02,6]undecanes, potential serotonergic 5‐HT1A receptors antagonists, was determined by means of the reversed‐phase RP‐18W and RP‐18 thin‐layer chromatography. The use of the linear (Soczewinski‐Wachtmeister) and square (Schoenmaker) equation for R MW calculation was evaluated. Due to the rather poor correlation between linear and square R MW values, despite very good correlation coefficients for independent measurements for each solvent system, the results of the RP‐18 measurements and use of the linear equation for the R MW calculation were found to be the most reliable. Their reliability was also confirmed by the best values of F and s. The standardization (for six standards of known lipophilicity – log P) allowed calculation of the experimental lipophilicities (log P EXP ) for compounds investigated.
Heterocyclic Communications | 2012
Bożena Kuran; Mariola Krawiecka; Jerzy Kossakowski; Ksenia Szymanek; Marta Kierzkowska; Młynarczyk G
Abstract Five aminoalkyl 1H-benzo[de]isoquinoline-1,3(2H)-diones were synthesized and evaluated for antimicrobial activity. Microorganisms used in this study included aerobic and facultative anaerobic bacteria Staphylococcus aureus, Escherichia coli and Stenotrophomonas maltophilia, and obligatory anaerobes Bacteroides fragilis, Bacteroides thetaiotaomicron and Propionibacterium acnes. Moreover, Candida albicans yeast was used. The minimum inhibitory concentration (MIC) was determined for the test compounds. Among the tested derivatives, two compounds 1 and 2 have shown the most potent antibacterial as well as antifungal activities.
Molecules | 2006
Jerzy Kossakowski; Mariola Krawiecka; Bożena Kuran
The preparation of a number of cyclic imide 5-HT(1A) receptor ligand derivatives has been described. Their structures were conformationally constrained by introducing rigid linkers containing unsaturated bonds or aromatic benzene rings. These compounds are expected to possess anxiolytic and antidepressant activity.
Heterocyclic Communications | 2013
Bożena Kuran; Jerzy Kossakowski; Marcin Cieślak; Julia Kazmierczak-Barańska; Karolina Królewska; Michał K. Cyrański; Dorota K. Stępień; Mariola Krawiecka
Abstract In the search for biological agents, a series of new N-substituted ethyl 11-ethyl-7-methyl-3,5,10-trioxo-4-azatricyclo[5.2.2.02,6]undecane-8-carboxylates 3, 9-methyl-3,5,8-trioxo-4-azatricyclo[5.2.1.02,6]dec-1-yl acetates 6 and 1,3-dioxo-4,5,6,7-tetraphenyl-2,3,3a,4,5,7a-hexahydro-1H-isoindole-4-carboxylic acids 9 were prepared. All compounds were characterized by 1H NMR, ESI-MS, and elemental analyses. Moreover, for intermediate products 2, 5, and 8, X-ray structural analyses were conducted. Compounds 3a–e, 6a, 6b, 9a–e were tested for their cytotoxic properties in K562 and HeLa cells.
Anti-cancer Agents in Medicinal Chemistry | 2016
Bożena Kuran; Mariola Napiórkowska; Jerzy Kossakowski; Marcin Cieślak; Julia Kaźmierczak-Barańska; Karolina Królewska; Barbara Nawrot
A large group of aminoalkyl and aminoalkanol derivatives of selected dicarboximides were synthesized and characterized by 1HNMR, 13CNMR and ESI MS spectra analysis. The thirty nine new compounds were tested for their cytotoxic properties in human chronic (K562), acute leukemia (HL-60), and cervical cancer cells (HeLa) as well as in normal endothelial cells (HUVEC). The most promising compounds are 4-[2-(dimethylamino)ethyl]-, (diethylamino) ethyl]-, 4-[2-(piperidin-1-yl)ethyl]-, 4-[3-(dimethylamino)propyl]- and 4-[2-hydroxy-3-(propan- 2-ylamino)propyl]- derivatives of 1,7-diethyl-8,9-diphenyl-4-azatricyclo[5.2.1.0(2,6)]dec-8-ene-3,5,10-trione exhibiting high and selective cytotoxicity towards K562 and HL-60 cells (IC50 in the range of 1-10 µM) while being non-toxic towards HUVEC and HeLa cells (IC50> 100 μM). Moreover, the preliminary studies have showed that 4-[2-(piperidin-1-yl)ethyl]- 1,7-diethyl-8,9-diphenyl-4-azatricyclo [5.2.1.0(2,6)]dec-8-ene-3,5,10-trione induces programmed cell death (apoptosis) in leukemia cells.
Heterocyclic Communications | 2015
Mariola Napiórkowska; Marcin Cieślak; Julia Kaźmierczak-Barańska; Karolina Królewska; Aleksandra Czapla; Bożena Kuran
Abstract A series of 38 new derivatives of cyclic imides containing silicon in the structure was synthesized and characterized by 1H NMR, ESI-MS, and elemental analysis. Selected compounds (1l,m, 1g, 1o,p, 2l,m, and 2o,p) were tested for their cytotoxic properties in human chronic myelogenous leukemia (K562), human cervical cancer (HeLa), and normal endothelial cells (HUVEC). Seven compounds showed significant cytotoxicity. In addition, two compounds (1l and 2l) were tested toward affinity for 5-HT1A, 5-HT6, and 5-HT7 serotonin receptors, and all aryl/heteroarylopiperazino derivatives were tested for antimicrobial activity. The compounds tested toward affinity for selected serotonin receptors showed high and moderate affinity for 5-HT1A and 5-HT7, while the antimicrobial activity of tested compounds was not significant.
Heterocyclic Communications | 2013
Mariola Krawiecka; Bożena Kuran; Jerzy Kossakowski; Marta Kierzkowska; Młynarczyk G; Julia Kazmierczak-Barańska; Karolina Królewska; Marcin Cieślak
Abstract In the search for new antimicrobial and anticancer agents, a series of (aryl/heteroaryl-piperazino-alkyl)-substituted derivatives of benzo[b]furans were prepared. All compounds were characterized by 1H NMR, 13C NMR, ESI-MS spectra and elemental analyses. Most of the investigated compounds had no antimicrobial activity (MIC > 512 mg/L) except for 2l, 2m and 2o, which showed activity against Candida albicans. None of the tested compounds showed significant anticancer activity in K562 and HeLa cells.
Anti-cancer Agents in Medicinal Chemistry | 2014
Mariola Krawiecka; Bożena Kuran; Jerzy Kossakowski; Marcin Cieslak; Julia Kazmierczak Baranska; Karolina Królewska; Barbara Nawrot
Archive | 2015
Jerzy Kossakowski; Bożena Kuran; Julia Kazmierczak-Baranska; Karolina Królewska; Barbara Nawrot; Mariola Krawiecka; Marcin Cieslak
Archive | 2014
Bożena Kuran; Mariola Krawiecka; Jerzy Kossakowski; Marcin Cieslak; Julia Kazmierczak-Baranska; Karolina Królewska; Barbara Nawrot